However, metformin treatment did not show any effects on methionine-choline-deficient- (MCD-) induced increases in mTOR activity or the NASH phenotype, such as inflammation and collagen deposition, in NASH mice [90]. Here, MTOR is linked to metabolic dysfunction-associated steatohepatitis.